Skip to main content

Table 1 Clinicopathological characteristics and URG4 expression in the cervical cancer patients

From: URG4 overexpression is correlated with cervical cancer progression and poor prognosis in patients with early-stage cervical cancer

  Number of cases (%)
Age, years  
≥42 93 (55.7)
<42 74 (44.3)
Squamous cell carcinoma antigen, ng/ml
≤1.5 97 (58.1)
>1.5 51 (30.5)
No test 19 (11.4)
FIGO stage  
Ib1 68 (40.7)
Ib2 59 (35.3)
IIa1 38 (22.8)
IIa2 2 (1.2)
Tumour size, cm  
<4 106 (63.5)
≥4 61 (36.5)
Histological type  
Squamous cell carcinoma 153 (91.6)
Adeno cell carcinoma 14 (8.4)
Histological differentiation  
Well 8 (4.8)
Moderate 66 (39.5)
Poor 93 (55.7)
Deep stromal invasion  
No 67 (40.1)
Yes 100 (59.9)
Lymphovascular space involvement  
No 160 (95.8)
Yes 7 (4.2)
Positive parametrium  
No 162 (97)
Yes 5 (2.4)
Positive surgical margin  
No 164 (98.2)
Yes 3 (1.8)
Vaginal involvement  
No 157 (94.0)
Yes 10 (6.0)
T classification  
T1b1 113 (67.7)
T1b2 39 (23.4)
T2a 9 (5.4)
T2b 4 (2.4)
T4 2 (1.2)
N classification  
N0 140 (83.8)
N1 27 (16.2)
M classification  
No 160 (95.8)
Yes 7 (4.2)
Concurrent chemotherapy and radiotherapy  
No 59 (62.1)
Yes 36 (37.9)
Radiotherapy  
No 49 (68.1)
Yes 23 (31.9)
Recurrence  
No 148 (88.6)
Yes 19 (11.4)
Vital status (at follow-up)  
Alive 155 (92.8)
Dead 12 (7.2)
URG4 expression  
Low or no expression 108 (64.7)
High expression 59 (35.3)
0)
\